Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and fibromyalgia: PR3-versus MPO-ANCA-associated vasculitis, an exploratory cross-sectional studyResearch in context

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and fibromyalgia: PR3-versus MPO-ANCA-associated vasculitis, an exploratory cross-sectional studyResearch in context

Summary: Background: Persistent fatigue is a common complaint in ANCA-vasculitis (AAV) patients and has a profound impact on patient's quality of life. The symptoms associated with this fatigue mirror those found in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and...

Full description

Bibliographic Details
Main Authors:	Charmaine van Eeden, Naima Mohazab, Desiree Redmond, Elaine Yacyshyn, Alison Clifford, Anthony S. Russell, Mohammed S. Osman, Jan Willem Cohen Tervaert
Format:	Article
Language:	English
Published:	Elsevier 2023-04-01
Series:	The Lancet Regional Health. Americas
Subjects:	Fatigue Myalgic encephalomyelitis/chronic fatigue syndrome Fibromyalgia Antineutrophil cytoplasmic antibody (ANCA)-Associated vasculitis Proteinase 3 (PR3) associated ANCA vasculitis Myeloperoxidase (MPO) associated vasculitis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667193X23000340

Similar Items

Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival
by: Wei Lin, et al.
Published: (2021-03-01)

Presentation and progression of MPO-ANCA interstitial lung disease
by: Lorenzo Salvati, et al.
Published: (2024-06-01)

Relationship between serologic profile (ANCA type) and clinical features of renal involvement in ANCA-associated vasculitides
by: N M Bulanov, et al.
Published: (2018-06-01)

Newly diagnosed ANCA-associated vasculitis after COVID-19 infection: a case report
by: Kazuhiro Kitamoto, et al.
Published: (2023-08-01)

Rituximab in relapsing and de novo MPO ANCA-associated vasculitis with severe renal involvement: a case series
by: L. Caroti, et al.
Published: (2019-05-01)

Type of ANCA May Be Indispensable in Distinguishing Subphenotypes of Different Clinical Entities in ANCA-Associated Vasculitis
by: Afroditi Maria Konstantouli, et al.
Published: (2022-09-01)

Renal thrombotic microangiopathy in an ANCA-associated vasculitis
by: Ana Teresa Domingos, et al.
Published: (2019-10-01)

ANCA-associated vasculitis overlaps with systemic sclerosis: a case report and literature review
by: Rui Wu, et al.
Published: (2021-03-01)

Altered circulating CCR6+and CXCR3+ T cell subsets are associated with poor renal prognosis in MPO-ANCA-associated vasculitis
by: Zhonghua Liao, et al.
Published: (2021-07-01)

Clinical characteristics and primary outcomes of patients with ANCA-associated vasculitis and central diabetes insipidus
by: Xin Chen, et al.
Published: (2023-05-01)

Rituximab induction therapy for de novo ANCA associated vasculitis in pregnancy: a case report
by: Claire Harris, et al.
Published: (2018-06-01)

ANCA-associated vasculitis in a 14 years-old patient: a clinical case
by: A. V. Burlutskaya, et al.
Published: (2020-10-01)

Pathogenesis and Diagnosis of Otitis Media with ANCA-Associated Vasculitis
by: Naohiro Yoshida, et al.
Published: (2014-01-01)

Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients
by: Xueling Hu, et al.
Published: (2022-10-01)

ANCA-associated Leucocytoclastic Vasculitis presenting with Bronchiectasis, GI Involvement and Hypertensive Urgency: A Complex Case without Renal Involvement
by: N. M. M. Risly, et al.
Published: (2024-12-01)

A case of COVID‐19‐associated C‐ANCA vasculitis, was successfully treated with rituximab therapy
by: Michael Filoramo, et al.
Published: (2024-08-01)

Implication of platelets and complement C3 as link between innate immunity and tubulointerstitial injury in renal vasculitis with MPO-ANCA seropositivity
by: Eva Baier, et al.
Published: (2022-11-01)

Methimazole-Induced ANCA Vasculitis: A Case Report
by: Precil Diego Miranda de Menezes Neves, et al.
Published: (2021-08-01)

Improvement of indirect immunofluorescence technique to detect antineutrophil cytoplasmic antibodies and its impact on test positivity rate
by: E.B. Zarur, et al.
Published: (2023-07-01)

Sequential development of ANCA‐associated vasculitis and anti‐GBM disease: A report of two cases
by: Camille Le Moine, et al.
Published: (2021-07-01)

Ischaemic stroke as the first presentation of antineutrophilic cytoplasmic autoantibody‐associated vasculitis
by: John Chuan Nguyen Tran, et al.
Published: (2022-12-01)

Diagnostic and treatment challenge of unrecognized subacute bacterial endocarditis associated with ANCA-PR3 positive immunocomplex glomerulonephritis: a case report and literature review
by: D. Bele, et al.
Published: (2020-01-01)

Environmental factors influencing the risk of ANCA-associated vasculitis
by: Wen-Man Zhao, et al.
Published: (2022-09-01)

Hypophysitis Secondary to Small Vessel ANCA Vasculitis Treated With Rituximab
by: Nankee K. Kumar, AB, et al.
Published: (2024-03-01)

Automated Computational Detection of Disease Activity in ANCA-Associated Glomerulonephritis Using Raman Spectroscopy: A Pilot Study
by: Adam D. Morris, et al.
Published: (2022-04-01)

Comprehensive Analysis of Sex Differences at Disease Manifestation in ANCA-Associated Glomerulonephritis
by: Désirée Tampe, et al.
Published: (2021-09-01)

Rare Case of Renal Limited Dual Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: Double Trouble!
by: Elenjickal Elias John, et al.
Published: (2022-05-01)

Comparative Histological Subtyping of Immune Cell Infiltrates in MPO-ANCA and PR3-ANCA Glomerulonephritis
by: Samy Hakroush, et al.
Published: (2021-10-01)

ANCA-Positive Small-Vessel Vasculitis Following SARS-CoV-2 Vaccination—A Systematic Review
by: Kinga Łysak, et al.
Published: (2024-06-01)

Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse
by: Matthew David Morgan, et al.
Published: (2017-06-01)

Complement Inhibition in ANCA-Associated Vasculitis
by: Vladimir Tesar, et al.
Published: (2022-07-01)

Blue toe syndrome as the initial manifestation of ANCA-associated vasculitis
by: Marinchev Liubomir, et al.
Published: (2013-10-01)

Development of a radiomics nomogram to predict the treatment resistance of Chinese MPO-AAV patients with lung involvement: a two-center study
by: Juan Chen, et al.
Published: (2023-07-01)

Antineutrophil cytoplasmic antibody positivity and cutaneous IgA vasculitis in a patient with antisynthetase syndrome
by: Delfina Bur, BA, et al.
Published: (2021-12-01)

Favorable efficacy of rituximab in ANCA-associated vasculitis patients with excessive B cell differentiation
by: Yusuke Miyazaki, et al.
Published: (2020-06-01)

Plasma Exchange for ANCA-Associated Vasculitis: An International Survey of Patient PreferencesPlain Language Summary
by: David Collister, et al.
Published: (2023-03-01)

ANCA vasculitis in a patient with Alport syndrome: a difficult diagnosis but a treatable disease!
by: Valentine Gillion, et al.
Published: (2017-03-01)

New‐onset ANCA‐associated vasculitis presenting with neuropathy after COVID‐19 infection: A case report and literature review
by: Aida Mohamadi, et al.
Published: (2024-01-01)

Association of HLA-class II alleles with risk of relapse in myeloperoxidase-antineutrophil cytoplasmic antibody positive vasculitis in the Japanese population
by: Aya Kawasaki, et al.
Published: (2023-03-01)

Granulomatosis with Polyangiitis Restricted to the Back Muscle: The First Case Report
by: Yu-Mi Lee, et al.
Published: (2020-08-01)